Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Oct 5;2011(10):CD003956.
doi: 10.1002/14651858.CD003956.pub2.

Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia

Affiliations
Meta-Analysis

Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia

Mohan Pammi et al. Cochrane Database Syst Rev. .

Abstract

Background: Neonates have immature granulopoiesis, which frequently results in neutropenia after sepsis. Neutropaenic septic neonates have a higher mortality than non-neutropenic septic neonates. Therefore, granulocyte transfusion to septic neutropenic neonates may improve outcomes.

Objectives: The primary objective was to determine the effect of granulocyte or buffy coat transfusions as adjuncts to antibiotics, after confirmed or suspected sepsis in neutropenic neonates, on all-cause mortality during hospital stay and neurological outcome at ≥ year of age. Secondary objectives were to determine the effects of granulocyte transfusions on length of hospital stay in survivors to discharge, adverse effects and immunologic outcomes at ≥ year of age.

Search strategy: The Cochrane Central Register of Controlled Trials (The Cochrane Library), MEDLINE, EMBASE and CINAHL, proceedings of the PAS conferences and ongoing trials at clinicaltrials.gov and clinical-trials.com were searched in July 2011.

Selection criteria: Studies where neutropenic neonates with suspected or confirmed sepsis were randomised or quasi-randomised to granulocyte or buffy coat transfusions at any dose or duration, and reporting any outcome of interest were included.

Data collection and analysis: Relative risk (RR) and risk difference (RD) with 95% confidence intervals using the fixed effects model were reported for dichotomous outcomes. Pre-specified subgroup analyses were performed.

Main results: Four trials were eligible for inclusion. Forty-four infants with sepsis and neutropenia were randomised in three trials to granulocyte transfusions or placebo/no transfusion. In another trial, 35 infants with sepsis and neutropenia on antibiotics were randomised to granulocyte transfusion or IVIG.When granulocyte transfusion was compared with placebo or no transfusion, there was no significant difference in 'all-cause mortality' (three trials; typical RR 0.89, 95% CI 0.43 to 1.86; typical RD -0.05, 95% CI -0.31 to 0.21).When granulocyte transfusion was compared with intravenous immunoglobulin (one trial), there was a reduction in 'all-cause mortality' of borderline statistical significance (RR 0.06, 95% CI 0.00 to 1.04; RD -0.34, 95% CI -0.60 to -0.09; NNT 2.7, 95% CI 1.6 to 9.1).Pulmonary complications were the only adverse effect reported in the trials that used buffy coat transfusions. None of the trials reported on neurological outcome at one year of age or later, length of hospital stay in survivors to discharge or immunological outcome at one year of age or later.

Authors' conclusions: Currently, there is inconclusive evidence from randomised controlled trials (RCTs) to support or refute the routine use of granulocyte transfusions in neutropenic, septic neonates. Researchers are encouraged to conduct adequately powered multi-centre trials of granulocyte transfusions in neutropenic septic neonates.

PubMed Disclaimer

Conflict of interest statement

None

Figures

1.1
1.1. Analysis
Comparison 1 Granulocyte transfusion vs placebo or no intervention, Outcome 1 All‐cause mortality during hospital stay.
2.1
2.1. Analysis
Comparison 2 Granulocyte transfusion vs IVIG, Outcome 1 All cause mortality during hospital stay.

Update of

References

References to studies included in this review

Baley 1987 {published data only}
    1. Baley JE, Stork EK, Warkentin PI, Shurin SB. Buffy coat transfusions in neutropenic neonates with presumed sepsis: A prospective randomized trial. Pediatrics 1987;80:712‐9. - PubMed
Cairo 1992 {published data only}
    1. Cairo MS, Worcester CC, Rucker RW, Hanten S, Amlie RN, Sender L, Hicks DA. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. Journal of Pediatrics 1992;120:281‐5. - PubMed
Christensen 1982 {published data only}
    1. Christensen RD, Rothstein G, Anstall HB, Bybee B. Granulocyte transfusions in neonates with bacterial infection, neutropenia and depletion of mature marrow neutrophils. Pediatrics 1982;70:1‐6. - PubMed
Wheeler 1987 {published data only}
    1. Wheeler JG, Chauvenet AR, Johnson CA, Block SM, Dillard R, Abramson JS. Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics 1987;79:422‐5. - PubMed
    1. Wheeler JG, Chauvenet AR, Johnson CA, Dillard R, Block SM, Boyle R, Abramson JS. Neutrophil storage pool depletion in septic, neutropenic neonates. Pediatric Infectious Disease Journal 1984;3:407‐9. - PubMed

References to studies excluded from this review

Cairo 1987 {published data only}
    1. Cairo MS, Rucker R, Bennetts GA, Hicks D, Worcester C, Amlie R, Johnson S, Katz J. Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics 1984;74:887‐92. - PubMed
    1. Cairo MS, Worcester C, Rucker R, Bennetts GA, Amlie R, Perkin R, Anas N, Hicks D. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. Journal of Pediatrics 1987;110:935‐41. - PubMed
Laing 1983 {published data only}
    1. Laing IA, Boulton FE, Hume R. Polymorphonuclear leucocyte transfusion in neonatal septicaemia. Archives of Disease in Childhood 1983;58:1003‐5. - PMC - PubMed
Laurenti 1979 {published data only}
    1. Laurenti F, Ferro R, Colarizi P, Mendicini M, Isaachi G, Malagnino F, Rossini M, Bucci G. Granulocyte transfusions in very premature infants with sepsis. Pediatric Research 1980;14 (part 2):169 (abstract 18).
    1. Laurenti F, Ferro R, Berardinis M, Crispino P, Malagnino F, Isacchi G, Rossini M. Treatment with granulocyte concentrates in VLBW infants [Terapia con concentrato Di' granulociti nei prematuri di peso molto basso con sepsi]. Acta Pediatrica‐Latina 1979;32:709‐13.
Laurenti 1980 {published data only}
    1. Laurenti F, Ferro R, Colarizi P, Mendicini M, Isaachi G, Malagnino F, Rossini M, Bucci G. Polymorphonuclear leukocytes (PMN) transfusion for the treatment of neonatal sepsis. Pediatric Research 1980;14 (part 2):1424 (abstract 61).

Additional references

al‐Mulla 1995
    1. al‐Mulla ZS, Christensen RD. Neutropenia in the neonate. Clinics in Perinatology 1995;22:711‐39. - PubMed
Carr 2000
    1. Carr R. Neutrophil production and function in newborn infants. British Journal of Haematology 2000;110:18‐28. - PubMed
Carr 2003
    1. Carr R, Modi N, Doré C. G‐CSF and GM‐CSF for treating or preventing neonatal infections. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003066] - DOI - PMC - PubMed
Cesaro 2003
    1. Cesaro S, Chinello P, Silvestro G, Marson P, Picco G, Varotto S, Pittalis S, Zanesco L. Granulocyte transfusions from G‐CSF‐stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco‐hematological diseases. Support Care Cancer 2003;11:101‐6. - PubMed
Chanock 1996
    1. Chanock SJ, Gorlin JB. Granulocyte transfusions: Time for a second look. Infectious Disease Clinics of North America 1996;10:327‐43. - PubMed
Dale 1997
    1. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. British Journal of Haematology 1997;98:497‐501. - PubMed
Engelfriet 2000
    1. Engelfriet CP, Reesink HW, Klein HG, Murphy MF, Pamphilon D, Devereux S, Hocker P, Adkins D, Boyce N, Tobin S, Grigg A, Strauss RG, Liles WC, Price TH, Dale DC, Norol F. Granulocyte transfusions: International forum. Vox Sanguinis 2000;79:59‐66. - PubMed
Fanaroff 1998
    1. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Pediatric Infectious Disease Journal 1998;17:593‐8. - PubMed
Floss 1985
    1. Floss AM, Strauss RG, Goeken N, Knox L. Multiple transfusions fail to provoke antibodies against blood cell antigens in human infants. Transfusion 1985;26:419‐22. - PubMed
Gladstone 1990
    1. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A ten‐year review of neonatal sepsis and comparison with the previous fifty‐year experience. Pediatric Infectious Disease Journal 1990;9:819‐25. - PubMed
Grether 1997
    1. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278:207‐11. - PubMed
Grigull 2006a
    1. Grigull L, Beilken A, Schmid H, Kirschner P, Sykora K, Linderkamp C, et al. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G‐CSF‐mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer 2006;14:783‐6. - PubMed
Grigull 2006b
    1. Grigull L, Pulver N, Goudeva L, Sykora K, Linderkamp C, Beilken A, et al. G‐CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 2006;14:910‐6. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). In: Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011, Version 5.1.0 [updated March 2011] edition.
Hill 1987
    1. Hill HR. Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatric Research 1987;22:375‐82. - PubMed
Hill 1991
    1. Hill HR. Granulocyte transfusions in neonates. Pediatrics in Review 1991;12:298‐302. - PubMed
Isaacs 1995
    1. Isaacs D, Barfield CP, Grimwood K, McPhee AJ, Minutillo C, Tudehope DI. Systemic bacterial and fungal infections in infants in Australian neonatal units. Medical Journal of Australia 1995;162:198‐201. - PubMed
Laurenti 1981
    1. Laurenti F, Ferro R, Isacchi G, Panero A, Savignoni PG, Malagnino F, et al. Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. Journal of Pediatrics 1981;98:118‐23. - PubMed
Levy 1998
    1. Levy SB. Antimicrobial resistance: Bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment. BMJ 1998;317:612‐3. - PMC - PubMed
Manroe 1979
    1. Manroe BL, Weinberg AG, Rosenfield CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. Journal of Pediatrics 1979;95:89‐98. - PubMed
McCullough 1983
    1. McCullough J. Granulocyte antigen systems, antibodies and their clinical significance. Human Pathology 1983;14:228‐34. - PubMed
McCullough 1986
    1. McCullough J, Clay M, Hurd D, Richards K, Ludvigsen C, Forstrom L. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival and tissue localisation of 111‐indium granulocytes. Blood 1986;67:522‐8. - PubMed
Mehr 2002
    1. Mehr SS, Sadowsky JL, Doyle LW, Carr J. Sepsis in neonatal intensive care in the late 1990s. Journal of Paediatrics and Child Health 2002;38:246‐51. - PubMed
Reiss 1982
    1. Reiss RF, Pindyck J, Waldman AA, Raju M, Kulpa J. Transfusion of granulocyte rich buffy coats to neutropenic patients. Medical and Pediatric Oncology 1982;10:447‐54. - PubMed
Rodwell 1993
    1. Rodwell RL, Taylor KM, Tudehope DI, Gray PH. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatric Infectious Disease Journal 1993;12:372‐6. - PubMed
Sachs 2006
    1. Sachs UJH, Reiter A, Walter T, Bein G, Woessmann W. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006;46:1909‐14. - PubMed
Stegagno 1985
    1. Stegagno M, Pascone R, Colarizi P, Laurenti F, Isaachi G, Bucci G, Luca EC. Immunologic follow‐up of infants treated with granulocyte transfusion for neonatal sepsis. Pediatrics 1985;76:508‐11. - PubMed
Stoll 1996a
    1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Early‐onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics 1996;129:72‐80. - PubMed
Stoll 1996b
    1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late‐onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health Development Neonatal Research Network. Journal of Pediatrics 1996;129:63‐71. - PubMed
Stoll 2002
    1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early‐onset sepsis in very‐low‐birth‐weight infants. New England Journal of Medicine 2002;347:240‐7. - PubMed
Vamvakas 1996
    1. Vamvakas EC, Pineda AA. Meta‐analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. Journal of Clinical Apheresis 1996;11:1‐9. - PubMed
Wheater 2000
    1. Wheater M, Rennie JM. Perinatal infection is an important risk factor for cerebral palsy in very low birth weight infants. Developmental Medicine and Child Neurology 2000;42:364‐7. - PubMed

References to other published versions of this review

Pammi 2003
    1. Pammi M, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003956] - DOI - PubMed

MeSH terms

Substances